Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2020

Open Access 01-12-2020 | SARS-CoV-2 | Case report

Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report

Authors: Maria Chiara Pelle, Bruno Tassone, Marco Ricchio, Maria Mazzitelli, Chiara Davoli, Giada Procopio, Anna Cancelliere, Valentina La Gamba, Elena Lio, Giovanni Matera, Angela Quirino, Giorgio Settimo Barreca, Enrico Maria Trecarichi, Carlo Torti, IDTM UMG COVID-19 Group

Published in: Journal of Medical Case Reports | Issue 1/2020

Login to get access

Abstract

Background

In December 2019, a new coronavirus (named severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) spread from China, causing a pandemic in a very short time. The main clinical presentation of SARS-CoV-2 infection (COVID-19, coronavirus disease-2019) is pneumonia, but several cardiovascular complications may also occur (e.g., acute coronary syndromes, pulmonary embolism, stroke, arrhythmias, heart failure and cardiogenic shock). Direct or indirect mechanisms induced by SARS-CoV-2 could be implicated in the pathogenesis of these events.

Case presentation

We report herein the third case of COVID-19 autoimmune haemolytic anaemia (AIHA) reported so far, which occurredwithout any other possible explanations in a Caucasian patient. The patient also suffered from ST-elevation myocardial injury.

Conclusions

Both complications occurred quite late after COVID-19 diagnosis and were probably precipitated by systemic inflammation, as indicated by a significant delayed increase in inflammatory markers, including interleukin-6 (IL-6).
Literature
1.
go back to reference Manish Bansal. Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Volume 14, Issue 3, May–June 2020, Pages 247-250. Manish Bansal. Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Volume 14, Issue 3, May–June 2020, Pages 247-250.
2.
go back to reference Hindilerden F, Yonal-Hindilerden I, Akar E, Yesilbag Z, Kart-Yasar K. Severe autoimmune haemolytic anemia in COVID-19 infection, safely treated with steroids. Mediterr J Hematol Infect Dis. 2020;12(1):e2020053.CrossRef Hindilerden F, Yonal-Hindilerden I, Akar E, Yesilbag Z, Kart-Yasar K. Severe autoimmune haemolytic anemia in COVID-19 infection, safely treated with steroids. Mediterr J Hematol Infect Dis. 2020;12(1):e2020053.CrossRef
3.
go back to reference Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [published online ahead of print, 2020 Mar 20]. Int J Antimicrob Agents. 2020;2020:105949.CrossRef Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [published online ahead of print, 2020 Mar 20]. Int J Antimicrob Agents. 2020;2020:105949.CrossRef
4.
go back to reference Vademecum for the treatment of people with COVID-19 disease. Edition 2.0, 13 March 2020. Lombardy Section of the Italian Society of Infectious and Tropical Diseases. InfezMed 2020; 28 (2), 143-152 Vademecum for the treatment of people with COVID-19 disease. Edition 2.0, 13 March 2020. Lombardy Section of the Italian Society of Infectious and Tropical Diseases. InfezMed 2020; 28 (2), 143-152
5.
go back to reference SmilgNicolás C, TornelSánchez G. Javier Trujillo Santos Concordance Among Venous Thromboembolism Risk Assessment Models. Med Clin (Barc). 2018;150(2):61–3.CrossRef SmilgNicolás C, TornelSánchez G. Javier Trujillo Santos Concordance Among Venous Thromboembolism Risk Assessment Models. Med Clin (Barc). 2018;150(2):61–3.CrossRef
6.
go back to reference La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–77.CrossRef La Rosée P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–77.CrossRef
7.
go back to reference Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12:8–15.CrossRef Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12:8–15.CrossRef
8.
go back to reference Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med, 2020. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med, 2020.
9.
go back to reference Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020;395(10229):1054-1062. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020;395(10229):1054-1062.
10.
go back to reference Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China [published correction appears in Lancet. 2020 Jan 30]. Lancet. 2020;395(10223):497–506.CrossRef Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China [published correction appears in Lancet. 2020 Jan 30]. Lancet. 2020;395(10223):497–506.CrossRef
11.
go back to reference Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531–8.CrossRef Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531–8.CrossRef
13.
go back to reference Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan China [published online ahead of print, 2020 Feb 7]. JAMA. 2020;323(11):1061–9.CrossRef Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan China [published online ahead of print, 2020 Feb 7]. JAMA. 2020;323(11):1061–9.CrossRef
14.
go back to reference M. Mazzitelli, F. Serapide, B. Tassone, D. Laganà, E. M. Trecarichi, and C. Torti, “Spontaneous and severe haematomas in patients with COVID-19 on low-molecular-weight heparin for paroxysmal atrial fibrillation” Mediterr. J. Hematol. Infect. Dis., vol. 12, no. 1, Art. no. 1, Jun. 2020. M. Mazzitelli, F. Serapide, B. Tassone, D. Laganà, E. M. Trecarichi, and C. Torti, “Spontaneous and severe haematomas in patients with COVID-19 on low-molecular-weight heparin for paroxysmal atrial fibrillation” Mediterr. J. Hematol. Infect. Dis., vol. 12, no. 1, Art. no. 1, Jun. 2020.
15.
go back to reference Matthias G, von Herrath MG, Oldstone MB. Virus-induced autoimmune disease. Curr Opin Immunol. 1996;8(6):878–85.CrossRef Matthias G, von Herrath MG, Oldstone MB. Virus-induced autoimmune disease. Curr Opin Immunol. 1996;8(6):878–85.CrossRef
16.
go back to reference Meite M, Léonard S, Idrissi ME, Izui S, Masson PL, Coutelier JP. Exacerbation of autoantibody-mediated hemolyticanemia by viral infection. J Virol. 2000;74(13):6045–9.CrossRef Meite M, Léonard S, Idrissi ME, Izui S, Masson PL, Coutelier JP. Exacerbation of autoantibody-mediated hemolyticanemia by viral infection. J Virol. 2000;74(13):6045–9.CrossRef
17.
go back to reference Lazarian G, Quinquenel A, Bellal M, Siavellis J, Jacquy C, Re D et al. Autoimmune haemolytic anemia associated with Covid-19 infection. Br J Haematol. 2020. Lazarian G, Quinquenel A, Bellal M, Siavellis J, Jacquy C, Re D et al. Autoimmune haemolytic anemia associated with Covid-19 infection. Br J Haematol. 2020.
18.
go back to reference Lopez C, Kim J, Pandey A, Huang T, DeLoughery TG. Simultaneous Onset of COVID-19 and Autoimmune Haemolytic Anaemia. Br J Haematol. 2020. Lopez C, Kim J, Pandey A, Huang T, DeLoughery TG. Simultaneous Onset of COVID-19 and Autoimmune Haemolytic Anaemia. Br J Haematol. 2020.
19.
go back to reference E. M. Trecarichi et al. Characteristics, outcome and predictors of in-hospital mortality in an elderly population from a SARS-CoV-2 outbreak in a long-term care facility. MedRxiv 2020.06.30.20143701 [preprint] E. M. Trecarichi et al. Characteristics, outcome and predictors of in-hospital mortality in an elderly population from a SARS-CoV-2 outbreak in a long-term care facility. MedRxiv 2020.06.30.20143701 [preprint]
20.
go back to reference Lechner K, Jäger U. How I treat autoimmune haemolytic anemias in adults. Blood. 2010;116(11):1831–8.CrossRef Lechner K, Jäger U. How I treat autoimmune haemolytic anemias in adults. Blood. 2010;116(11):1831–8.CrossRef
Metadata
Title
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report
Authors
Maria Chiara Pelle
Bruno Tassone
Marco Ricchio
Maria Mazzitelli
Chiara Davoli
Giada Procopio
Anna Cancelliere
Valentina La Gamba
Elena Lio
Giovanni Matera
Angela Quirino
Giorgio Settimo Barreca
Enrico Maria Trecarichi
Carlo Torti
IDTM UMG COVID-19 Group
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2020
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-020-02595-3

Other articles of this Issue 1/2020

Journal of Medical Case Reports 1/2020 Go to the issue